SillaJen (신라젠)Compare →
No per-source breakdown for this snapshot yet — it fills in from the next refresh.
Picked up by Daum only — may be platform-internal dynamics.
Sample — 1 cross-checked sources · 19 snapshots (5-min interval)
Not on the board right now — here's the record of when it was.
Why it's trending
SillaJen’s ‘BAL0891’ Designated as Orphan Drug by FDA… Secures AML Development Support Benefits— 팜이데일리
This is an actual headline, quoted as-is — never summarized or generated.
Related coverage
·
신라젠 first appeared on KoreaTrendBoard on August 25, 2026. It has been observed 19 times since, peaking at rank 9 with a score of 20.3. It was last seen on August 26, 2026.
Loading
This chart shows the last 14 days. Pro opens 180 days and lets you export the same data as CSV — one row per day with rank, score and source count. See what opens →
The full board on 2026-08-25 → · This week · Glossary
Picked up by: DaumReferenced from each site's publicly available rankings. No affiliation or partnership.
Want a heads-up when «신라젠» climbs again? It's free.
No signup form — your email is the account. One click to stop.
- 180-day history — the curve, not the moment
- Alerts — pinged within 5 minutes when your keyword moves
- API — ranks and scores straight into your report